Skip to main content
Journal of Ayurveda and Integrative Medicine logoLink to Journal of Ayurveda and Integrative Medicine
. 2023 Jun 2;14(3):100719. doi: 10.1016/j.jaim.2023.100719

Efficacy of Jatyadi, Madhughrita and honey tulle in wound management: a three-arm randomized controlled clinical trial

Dhrushnu Prasannan a, Pradeep S Shindhe a,, Prashant G Jadar b, Ramesh S Killedar a, Priyanka K a
PMCID: PMC10242641  PMID: 37271064

Abstract

Background

Ayurveda underlines the significance of wounds and wound healing. Acharya Susruta has highlighted the need for shastiupakramas in the management of the wound. Even with a multitude of therapeutic concepts and formulations in Ayurveda, wound management has yet to gain acceptance.

Objective

To evaluate the effect of Jatyadi tulle, Madhughrita tulle, and honey tulle in the management of Shuddhavrana (clean wound).

Materials and methods

A three-arm randomized, parallel group, active-controlled, open-label clinical trial. Randomization was done through online random number generator software to allocate 45 patients treatment into three groups. Trial groups were treated with Jatyadi tulle (JT), Madhughrita tulle (MG), and control group was treated with Honey tulle (HT) for 10 days, and assessment was done on the 5th and 10th day. The wound was assessed using the Bates Jensen wound assessment tool, and the efficacy of the dressing material was assessed using the Worcestershire tissue viability team dressing assessment form. The study outcomes were early wound healing and clinical cure.

Results

Within-group results were assessed using the Wilcoxon matched pairs test, and between-group results were assessed by Kruskal–Wallis ANOVA and Mann–Whitney U test. Significant results were obtained within-group (p value < 0.05) from day 0 and at various time points. The results between groups were found to be comparable; JT and MG were found to be significant in ease of application, removal, and patient comfort. No adverse drug events were identified throughout the study.

Conclusion

JT and MG tulle have shown significant results in the management of shuddhavrana.

Keywords: Vrana, Wound healing, Jatyadi tulle, Honey tulle, Madhughrita tulle

1. Introduction

1.1. Scientific background and explanation of rationale

A wound is a rupture in the skin's or tissue's integrity that is typically accompanied by an alteration of structure and function [1]. Wound healing is a natural biological process that occurs in four distinct and well-defined stages: haemostasis, inflammation, proliferation, and remodelling [2]. The wounds that heal within 4 weeks and that progress through normal phases of healing are termed “acute wounds”. This study mainly focuses on shuddhavrana (clean wound). According to Indian epidemiological data, chronic wounds were reported at 4.5 per 1000 population, whereas acute wounds were nearly doubled at 10.5 per 1000 population [3]. Wounds require proper cleansing and treatment with minimal adherent coverings to avoid infection and to promote healing. Picking the right dressing will speed up the healing process, reduce costs, and improve the patient's quality of life [4]. Modern science employs several forms of wound dressing based on the characteristics of the wound, such as low adherent, semi permeable, foam, hydro gel, hydrocolloid, etc. [5]. Tulle grass is a leno weave fabric gauze made of cotton, and which is categorised under low adherent dressing, being economical, safe, and widely available [6]. In the market, different types of tulles are available, like sofa tulle, bactigrass, paraffin tulle etc. which possess wound healing properties.

The necessity of wounds and wound healing is also emphasized in Ayurveda. Acharya Sushruta defined a wound as gatravichurnane, i.e., skin discontinuity, and classified it into two types based on doshadusti: dustavrana and shuddhavrana, where he clearly refers Shastiupakramas for wound treatment [7]. Under the heading of shastiupakramas, the usage of taila, ghrita, kashaya, rasakriya, etc. are mentioned as an external application, and the same is being practiced with good clinical results. The use of Madhughrita in wound management is mentioned in Sushruta Samhita and Jatyadi taila is mentioned in Saranghadara Samhita as a wound healing agent [[8], [9], [10]].

Jatyadi taila and madhughrita are routinely used in day-to-day clinical practice, but these formulations have struggled to acquire mainstream or commercial recognition. This might be owing to the difficulties in creating a homogeneous combination of madhu (honey) and ghrita (cow ghee), or it could be due to excessive drug loss during its application over the wound, or due to unequal drug distribution over the gauze piece, or due to drug contamination. To address this, we considered developing a readily available Ayurvedic surgical dressing material with jatyadi ointment and madhughrita for the management of shuddhavrana (healing wound).

1.2. Specific objectives or hypotheses

The purpose of this study was to formulate and therapeutically evaluate a dressing material made with Jatyadi ointment, Madhughrita, and compare it to a group of patients treated with honey tulle. The secondary objective was to know the efficacy of dressing materials in order to make an effective commercial wound dressing.

2. Methods and materials

(a) Trial design: The study was a three-arm randomized, parallel group, active-controlled, open-label clinical trial. Randomization was done through online random number generator software to allocate 45 patients treatment into three groups.

(b) Institutional Ethics Committee approval was obtained for the study (Protocol number - BMK/19/PG/ST/6) along with CTRI Registration (CTRI/2020/11/029090). The information regarding the treatment, risks, benefits were explained to the patients and written informed consent was obtained from them. No modifications to the methods were made after the trial commencement. Adherence to the designed study was present until the completion of the study. In reporting the study findings, the CONSORT statement guidelines were followed [11].

Sample size: A total of 45 patients were selected and divided into three groups (15 each).

Randomization: The study was a randomised controlled trial, and patients were randomly divided into three different groups by computer generated random number software. The CONSORT flow diagram of the study is provided in Fig. 1.

Fig. 1.

Fig. 1

CONSORT flow diagram of the study

Allocation of concealment mechanism: The patients were allocated to control and trial groups in a 1:1:1 ratio. The central case registration numbers were allotted to the patients as per the randomisation chart obtained by computer-generated random number.

Implementation: The patients were screened as per the inclusion and exclusion criteria by the investigators and treatment to the recruited patients were allotted as per the randomization chart.

Blinding: Study was open labeled and no blinding techniques were used.

3. Participants and preparation of formulations

3.1. Eligibility criteria for participants

Inclusive criteria - Patients with shuddhavrana [12] features, such as jihvatalobham (granulation tissue), mrudu (granulation tissue with a soft consistency), snighda (unctuous), slekshna (uniform epithelialization), vigatvedana (no pain), nirasrava (no abnormal discharge) and an age group between 20 years and 70 years were selected for the study from the OPD, IPD department of Shalyatantra, KAHER’s Shri B.M.K Ayurveda Hospital and Research Centre, Belagavi. The types of wounds included in the study were post-fistulectomy wound, traumatic wound, post incision and drainage wound, infected cyst excised wound, post pilonidal sinus excised wound, diabetic foot ulcer, and bedsore.

Exclusive criteria - Patients who were suffering from dustavrana (non healing wound) or with any known case of systemic diseases, malignant wounds, uncontrolled diabetes, HbsAg, HIV I and II were excluded from the study.

3.2. Settings and locations for the collection of the data

Irrespective of sex, caste and socio-economic status, a total of 45 patients (15 patients in each group) of shuddhavrana (acute clean wound) who visited the OPD and IPD department of Shalyatantra KAHER’s Shri B.M.K Ayurveda Hospital and Research Centre, Belagavi were enrolled for the study.

3.3. Raw drugs and finished products

3.3.1. Procurement

Drugs like madhuchista (bee wax), madhu (honey), ghrita (cow ghee) and jatyadi ointment were procured from GMP-certified KLE Ayurveda Pharmacy Khasbag, Belagavi. Leno weave gauze was procured from Lotus Surgical, Aurangabad. Identification and authentication of drugs were done at the AYUSH-certified ASU drug testing central research faculty of KAHER’s Shri BMK Ayurveda Mahavidyalaya, Belagavi. The Jatyadi tulle and Madhughrita tulle were prepared and packed in the GMP-certified KLE Ayurveda Pharmacy. Standard honey tulles were purchased from the market. Finished products were sent for gamma radiation sterilization at Microtrol Solutions, Bengaluru.

3.3.2. Preparation of the tulle

The preparation of tulle was done as per the prepared Standard Operation Procedure [13]. All the materials were autoclaved 24 h before the procedure, and the room was sterilized with potassium permanganate and formalin.

3.3.2.1. Jatyadi tulle

Jatyadi ointment was obtained from a GMP certified KLE Ayurveda pharmacy and was impregnated over autoclaved 10 × 10 cm tulle grass while following all aseptic precautions [14]. Excess material was removed from the tulle by applying pressure, and the tulle was kept in between sheets of butter paper, followed by sterile packing. The weight of the tulle was measured before and after the procedure, and the ointment present in the tulle was 3.54 g. Prepared tulle material was kept in between the butter papers and packed in an alu-plastic bag. These sealed packets were sent for 25 kGy gamma sterilization [15]. A diagram of finished products is provided in supplementary material.

3.3.2.2. Madhughrita tulle

Madhu and ghrita were taken in equal quantities for the preparation of tulle. 70 g of maduchista (beeswax) was heated under a low flame and, after it melted, 350 g of ghrita was added to it. After it was allowed to cool, 350 g of honey was added and stirred well to make an ointment. Separately, prepared madhughrita ointment was placed in the vessel, followed by dipping 10 × 10 cm tulle grass in the vessel and removing excess material from the tulle with pressure. The weight of the tulle was measured before and after the procedure, and the ointment present in the tulle was 3.54 g. Prepared tulle material was kept between the butter papers and packed in an alu-plastic bag. These sealed packets were sent for 25 kGy gamma sterilization.

4. Interventions

45 patients were randomly divided into three different groups, group JT - Jatyadi tulle (trial), group MG - Madhughrita tulle (trial), and group HT - Honey tulle (control group). In all the three groups, application of tulle was done once a day for duration of 10 days. The assessments were done on the 0th day, 5th day, and 10th day, and data was recorded systematically.

Data collection was done from March 2021 to January 2022. Patients were advised to inform any adverse events (AE) that occurred during the study to the principal investigator. In case of any AE, the patient was withdrawn from the study after following proper documentation, and providing information to the institutional ethical committee through the medical research centre.

5. Outcomes

5.1. Primary outcome

Assessment of the wound was done with Bates Jensen's wound evaluation criteria, which is an internationally recognized and more reliable wound assessment tool (Supplementary material) [16]. The study focused on shuddhavrana (healing wounds); therefore, wounds were assessed using Bates Jensen’s criteria 1, 3, 7, 9, 10, 12, and 13 (size, edge, exudates type, skin colour surrounding wound, peripheral tissue oedema, granulation tissue, and epithelialization) at various time periods (baseline, 5th and 10th day).

5.2. Secondary outcome

Assessment of the dressing material was done with a Worcestershire tissue dressing assessment form (Supplementary material), which was assessed on the 10th day of treatment. The parameters like ease of application, ease of removal, dressing stay as longer or shorter, patient comfort, and wound bed were analyzed using a questionnaire. The Worcestershire tissue dressing assessment form is used because it is found to be an internationally accepted and easiest method of assessment. Pre and Post treatment photography was taken to comment on the changes in the healing process.

6. Statistical methods

SPSS version 20.0 was used for the statistical analysis. Within the group, results were obtained using the Wilcoxon matched pairs test in different parameters like size, edge, exudates type, skin colour surrounding area, peripheral tissue oedema, granulation tissue, and epithelialization of the wound. The Kruskal–Wallis ANOVA and Mann–Whitney U test were performed to compare the three groups at different time points on assessment parameters. The Kruskal–Wallis ANOVA and Mann–Whitney U were used to assess the dressing material using the Worcestershire tissue viability team dressing assessment form.

7. Results

7.1. Subject characteristics

Age - In group JT out of 15 patients, 46.66% of patients were between the ages of 20 and 35 years, 20% were between the ages of 36 and 55 years, and 33.33% were between the ages of 56 and 70 years. In group MG, out of 15 patients, 40% were between the age groups of 20–35 years, 46.66% with an age group of 36–55 years, and 13.33% with an age group of 56–70 years. In Group HT, out of 15 patients, 46.66% were in the age group of 20–35 years, 26.66% in the age group of 36–55 years, and 26.66% in the age group of 56–70 years.

Gender - In terms of gender, 75.56% were men, while 24.44% were females, i.e., Group JT (12:3), Groups MG and HT (11:4). The overall majority of the patients (53.33%) were undergraduates as per education status.

Type of wound - Post fistulectomy wound (group JT - 46.66%, group MG - 53.33%, group HT - 26.66%), traumatic injury (JT: 13.33%, MG: 26.66%, HT: 20%), post incision and drainage wound (JT - 13.333%, MG - 20%, HT - 33.33%), excised wound from an infected cyst (JT - 13.33%), excised wound from a post pilonidal sinus (HT - 6.66%), bedsore (JT - 6.66%, HT - 6.66%), diabetic foot ulcer (JT - 6.66%, HT - 6.66%).

7.2. Primary outcome

Within the group’s results were statistically significant with a p-value <0.05 in all the three groups in relation to the assessment criteria like size, edge, exudates type, peripheral tissue oedema, granulation tissue, and epithelialization except in the case of skin colour surrounding the area of wound (Table 1, Table 2). In the comparison of three groups by Kruskal–Wallis Anova, the mean size of the wound was 2.73, 2.67, and 2.53 in respect to groups JT, MG, and HT (Table 2). Percentage - wise, Group JT (45.45%) had higher efficacy than groups MG (38.71%) and HT(35.48%) from Day 0 to Day 10 in terms of wound size and change in exudate type, i.e., groups JT (64.29%) and MG (65.91%) had more efficacy than group HT (42.31%). However, in terms of change in epithelialization, Group HT (53.62%) exceeded Groups JT (46.38%) and MG (40.28%). Between the groups, results were found to be comparable across all three groups (JT, MG, and HT). Before and after photographs were taken and shown in Fig. 2 - group treated with JT; Fig. 3 - group treated with MG; and Fig. 4 - group treated with HT.

Table 1.

Comparison (within the group) from day 1 to day 10 with parameters of Bates Jensen wound assessment tool.

Sl. No Parameter Changes From Group Mean Diff. SD Diff. % Of Change Z-Value p-Value
01 Size of Wound Day 0 – Day 10 JT 1.00 0.53 45.45 3.1798 0.0015∗
MG 0.80 0.56 38.71 2.9341 0.0033∗
HT 0.73 0.46 35.48 2.9341 0.0033∗
02 Edge of Wound Day 0 – Day 10 JT 1.60 0.51 58.54 3.4078 0.0007∗
MG 1.53 0.52 57.50 3.4078 0.0007∗∗
HT 1.40 0.74 55.26 3.1798 0.0015∗
03 Exudates Type Day 0 – Day 10 JT 1.80 0.86 64.29 3.4078 0.0007∗
MG 1.93 0.80 65.91 3.4078 0.0007∗
HT 1.73 0.80 63.41 3.2958 0.0010∗
04 Skin Colour Surrounding Area Day 0 – Day 10 JT 0.13 0.35 11.76 1.3416 0.1797
MG 0.27 0.46 21.05 1.8257 0.0679
HT 0.20 0.41 16.67 1.6036 0.1088
05 Peripheral Tissue Oedema Day 0 – Day 10 JT 0.27 0.46 21.05 1.8257 0.0289∗
MG 0.47 0.52 31.82 2.3664 0.0180∗
HT 0.47 0.52 31.82 2.3664 0.0180∗
06 Granulation Tissue Day 0 – Day 10 JT 1.60 0.63 52.17 3.4078 0.0007∗
MG 1.87 0.92 53.85 3.3226 0.0009∗
HT 1.67 0.90 56.82 3.1798 0.0015∗
07 Epithelialization Day 0 – Day 10 JT 2.13 1.30 46.38 3.2958 0.0010∗
MG 1.93 0.80 40.28 3.4078 0.0007∗
HT 2.47 1.46 53.62 3.1798 0.0015∗

Table 2.

Comparison (between the groups) from day 1 to day 10 with parameters of Bates Jensen wound assessment tool.

Sl. No Parameter Treatment Groups Mean Sd Mean Rank H-Value p-Value
1 Size of wound BT JT 2.73 0.46 24.77 0.6990 0.7050
MG 2.67 0.62 22.87
HT 2.53 0.64 21.37
AT JT 1.13 0.35 23.00 0.0000 1.0000
MG 1.13 0.35 23.00
HT 1.13 0.35 23.00
2 Edge of Wound BT JT 2.73 0.46 24.77 0.6990 0.7050
MG 2.67 0.62 22.87
HT 2.53 0.64 21.37
AT JT 1.13 0.35 23.00 0.0000 1.0000
MG 1.13 0.35 23.00
HT 1.13 0.35 23.00
3 Exudate Type BT JT 2.80 0.86 21.97 0.3760 0.8290
MG 2.93 0.80 24.50
HT 2.73 0.80 22.53
AT JT 1.00 0.00 23.00 0.0000 1.0000
MG 1.00 0.00 23.00
HT 1.00 0.00 23.00
4 Skin colour surrounding area BT JT 1.13 0.35 21.50 0.8150 0.6650
MG 1.27 0.46 24.50
HT 1.20 0.41 23.00
AT JT 1.00 0.00 23.00 0.0000 1.0000
MG 1.00 0.00 23.00
HT 1.00 0.00 23.00
5 Peripheral tissue oedema BT JT 1.27 0.46 20.00 1.6300 0.4430
MG 1.47 0.52 24.50
HT 1.47 0.52 24.50
AT JT 1.00 0.00 23.00 0.0000 1.0000
MG 1.00 0.00 23.00
HT 1.00 0.00 23.00
6 Granulation tissue BT JT 3.07 0.88 21.50 2.4790 0.2890
MG 3.47 0.64 27.03
HT 2.93 1.03 20.47
AT JT 1.47 0.52 24.77 1.3150 0.5180
MG 1.60 1.06 23.87
HT 1.27 0.46 20.37
7 Epithelialization BT JT 4.60 0.74 21.93 0.3260 0.8500
MG 4.80 0.41 23.90
HT 4.60 0.91 23.17
AT JT 2.47 1.36 22.47 3.7320 0.1550
MG 2.87 0.92 27.73
HT 2.13 1.25 18.80

Fig. 2.

Fig. 2

Wound of Trial group JT (0th day and 10th day)

Fig. 3.

Fig. 3

Wound of Trial group MG (0th day and 10th day)

Fig. 4.

Fig. 4

Wound of Control group HT (0th day and 10th day)

7.3. Secondary outcome

Groups JT and MG were found to be statistically significant with a p-value <0.05 in relation to ease of application, ease of removal, and patient comfort (Table 3). All the groups are comparable in relation to dressing stay and wound bed changes.

Table 3.

Comparison of three groups (JT, MG, HT) with status of Ease of application, Ease of removal, Patient comfort, Dressing stay as long/shorter and wound bed by Kruskal Wallis ANOVA.

Groups Ease of application
Ease of removal
Patient comfort
Dressing stay as long/shorter as recommended
Wound bed
Mean ± SD Mean rank Mean ± SD Mean rank Mean ± SD Mean rank Mean ± SD Mean rank Mean ± SD Mean rank
Group JT 3.87 ± 0.35 30.90 3.67 ± 0.62 29.80 3.67 ± 0.49 26.00 1.93 ± 0.26 22.00 3.00 ± 0.00 23.00
Group MG 3.60 ± 0.51 25.70 3.53 ± 0.52 26.67 3.73 ± 0.46 27.50 2.00 ± 0.00 23.50 3.00 ± 0.00 23.00
Group HT 2.73 ± 0.70 12.40 2.73 ± 0.46 12.53 3.20 ± 0.41 15.50 2.00 ± 0.00 23.50 3.00 ± 0.00 23.00
H-value 19.5620 17.9000 9.9520 2.0000 0.0000
P-value 0.0001∗ 0.0001∗ 0.0070∗ 0.3680 1.0000
Pair wise comparisons of groups A,B,C in relation to the Ease of application, Ease of removal, Patient comfort, Dressing stay as long/shorter as recommended by Mann–Whitney U test
Groups Ease of application Ease of removal Patient comfort Dressing stay as long/shorter as recommended Wound bed
Group JT vs Group MG p = 0.2211 p = 0.4429 p = 0.7716 p = 0.7716 p = 0.9835
Group JTvs Group HT p = 0.0003∗ p = 0.0006∗ p = 0.0310∗ p = 0.7716 p = 0.9835
Group MG vs Group HT p = 0.0037∗ p = 0.0023∗ p = 0.0136∗ p = 0.9835 p = 0.9835

∗p < 0.05

Harms - No adverse drug events were reported during the study.

8. Discussion

Wound healing would be a dynamic process that includes haemostasis, inflammation, proliferation, and remodelling [17]. Since the beginning of time, numerous kinds of dressings and dressing materials have been used to treat wounds. Optimal wound healing is dependent on the finest dressing material. A wide variety of dressing materials are available in modern science based on the features of the wound, of which only a few have potential data to back up their efficacy in improving wound healing [18]. Even with diverse medical formulations and various kinds of dressing materials, wound care is still a concern for a surgeon.

Size and edge of the wound - Significant size reduction was observed in JT and MG (Fig. 2, Fig. 3; Table 1, Table 2). Tikta (bitter), kashaya (astringent), rasa (taste), laghu (lightness), ruksha (roughness), gunas (properties) of JT act as vranaropana. Active phytochemicals like flavonoids, crucial oils (terpenoids), tannins (phenolics), glycosides, steroids, and alkaloids also help in early healing [19,20]. Ghrita in MG acts as vranaropana (healing) and kantivardhana (improving lustre) [21,22]. Honey's vranaropana capability, and its anti-bacterial and anti-inflammatory properties, aid in size reduction [23].

Significant results were observed in JT and MG. Jati (Myristica fragrans Houtt), Kushta (Saussurea lappa CB Clarke), Padmaka (Prunus puddum Roxb Ex. Wall), and Daruhardira (Berberis aristate DC.) are present in JT. It has kashaya (astringent), tikta (bitter), rasa (taste), kleda shoshana (drying of exudates) as well as lekhana (scraping) properties that help in the reduction of exudates [24]. The Alpa-abhishayandi (less oozing) property of ghrita and the vranashodana property of honey together helped in the reduction of exudate. Glucose oxidase present in honey produces hydrogen peroxide, which enhances the reduction of exudates [25].

Skin colour surrounding area -Significant results were not observed because most of the patients enrolled in our study had acute wounds of short duration. Only a few enrolled patients had chronic wounds with skin colour surrounding the area.

Peripheral tissue oedema - The significant results were observed in JT and MG. Ingredients like Patola (Trichosanthes dioica Roxb), Jati (M. fragrans Houtt), and Kushta (Saussurea lappa CB Clarke), present in JT, have shothahara (anti-inflammatory) property. Curcumin, present in haridra (Curcuma longa Linn) and salicylic acid, present in Jati, act as anti-inflammatory and anti-microbial agents, helping in the reduction of peripheral tissue oedema [26,27]. Sheeta (cold) guna and Kashaya rasa of honey act as vrana sothahara and ghrita acts as tridoshangna. Honey’s activity of cyclooxygenases 1 and 2 (COX1 and COX2) that intervene in the synthesis of prostaglandins helps in peripheral tissue odema [20]. Linoleic acid found in ghrita plays an important chemotaxic effect on microphages and promotes wound healing [28].

Granulation tissue - Significant results were observed in JT and MG. Manjishta (Rubia cordifolia Linn) and Sariva (Hemidesmus indicus R. Br) enhance the raktadhatu, which improves circulation and strengthens the sira (blood vessel) [29]. Katuka (Picrorhiza kurroa) found in the JT improves re-epithelialization, neovascularization, and migration of endothelial cells, dermal myofibroblasts, and fibroblasts into the wound bed [30]. Tuttha (CuSO4) promotes angiogenic responses in vitro and in vivo wound models, thus helping in the rapid filling of wound area with granulation tissue [31]. Tikta and kashaya rasa of honey aids in rakta shodhana (purification of blood) property. The Pittashamana and twak prasadana (to make skin healthy) properties of ghrita also play a role in improving local blood circulation. Honey's osmotic impact keeps the wound moist and clean, and promotes healthy granulation tissue growth [32].

Epithelialization - Significant findings were observed in JT and MG. The presence of tannins and phytosterols in JT material accelerates wound healing by boosting capillary production and fibroblast proliferation, hence accelerating the rate of epithelisation [33]. Madhura rasa of ghrita and honey help in prinana (nutrition), dhatuvardhana (tissue growth) and poshana (nourishment) of wounds, thus helping in epithelialization. Wound healing and cell migration experiments revealed that honey significantly increases the regeneration potential of skin cells, which can enhance the re-epithelialization of the wound [34,35].

Worcestershire wound assessment form - An ideal dressing material should keep the wound moist, protect it from trauma and infection, be simple to apply and remove, and be physically acceptable, or even pleasant [36]. The Worcestershire wound assessment form helped us to evaluate the excellence of the dressing material. Tulle grass, being a non-adherent substance, aids in the removal of dressing [37]. Taila and maduchista (bee wax) are present in JT and Ghrita present in MG with its Sneha (oleation) guna helps to keep the wound moist and promote wound healing. Beewax, being the non-adherent base material in both the groups (JT and MG), has the property to solidify the emulsified solutions and increase the water prevent capacity along with soothes and calms the skin [37]. The snighda (unctuous) guna of bee wax also aided in easy application, removal, and patient comfort [38].

Limitations - The study was conducted on acute clean wounds, but efficacy in all types of wounds, like chronic non-healing wounds, burns, etc., should be assessed to generate evidence-based practice and for global acceptance. The small sample size and short observation period are the other limitations of the study.

9. Conclusion

Ayurveda topical medicaments (Jatyadi tulle, Madhughrita tulle, Honey tulle) showed significant results within the group and between the groups results were comparable. Jatyadi tulle and Madhughrita tulle were found to be significant in relation to ease of application, ease of removal, and patient comfort. Jatyadi tulle and Madhughrita tulle were found effective in the management of shuddhavrana and can be considered as a good dressing material.

Source of funding

None.

Declaration of Competing Interest

None.

Acknowledgement

Dr.Suhas Kumar Shetty, Principal, KAHER's Shri B. M. Kankanawadi Ayurveda Mahavidyalaya, Shahapur, Belagavi and Microtrol Sterilisation Service, Bengaluru.

Footnotes

Peer review under responsibility of Transdisciplinary University, Bangalore.

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.jaim.2023.100719.

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.docx (104.3KB, docx)

References

  • 1.Sriram Bhat M., editor. SRB’S manual of surgery. 6th ed. Jaypee Brothers and Medical Publishers; New Delhi: 2017. [chapter 1] page. [Google Scholar]
  • 2.Guo S., Dipietro L.A. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229. doi: 10.1177/0022034509359125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gupta N., Gupta S.K., Shukla V.K., Singh S.P. An Indian community-based epidemiological study of wounds. J Wound Care. 2004 Sep;13(8):323–325. doi: 10.12968/jowc.2004.13.8.26657. PMID: 15469216. [DOI] [PubMed] [Google Scholar]
  • 4.Britto E.J., Nezwek T.A., Robins M. 2022 Jan. https://www.ncbi.nlm.nih.gov/books/NBK470199/# Wound Dressings. [Updated 2021 Jun 5]. In: statpearls [Internet]. Treasure Island (FL): statpearls Publishing. [PubMed]
  • 5.Dabiri G., Damstetter E., Phillips T. Choosing a wound dressing based on common wound characteristics. Adv Wound Care. 2016 Jan 1;5(1):32–41. doi: 10.1089/wound.2014.0586. PMID: 26858913; PMCID: PMC4717498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kumarjain Sudhir, Stoker David l, Ramantanwar, editors. Basic surgical skills and techniques. 3rd ed. Jaypee Brothers and Medical Punlishers; New Delhi: 2008. p. 117. [chapter 15] [Google Scholar]
  • 7.Murthy KR Srikanta., editor. Chaukhamba Orientalia; Varanasi: 2017. p. 165. (reprint edition 2017) English translated, Susruta Samhita of Acharya Susruta Sutra Sthana [Chapter 22] Verse 6. [Google Scholar]
  • 8.Murthy KR Srikanta., editor. Chaukhamba Orientalia; Varanasi: 2017. p. p115. (reprint edition 2017) English translated, Susruta Samhita of Acharya Susruta, Sutrastana Sthana [Chapter 16] Verse 15. [Google Scholar]
  • 9.Murthy KR Srikanta., editor. Chaukhamba Orientalia; Varanasi: 2017. p. 03. (reprint edition 2017) English translated, Susruta Samhita of Acharya Susruta Chikista, Sthana [Chapter 1] Verse 4. [Google Scholar]
  • 10.Ravindra Angadi, editor English translated, Sharangadara Samhita of Acharya Sharanghadara, Madhyama Khanda, [Chapter 9], Verse 168, 1st ed. 2017. Varanasi: Chaukhamba subharati prakashan. p 323.
  • 11.Schulz K.F., Altman D.G., Moher D. CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi: 10.1186/1741-7015-8-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Murthy KR Srikanta., editor. Chaukhamba Orientalia; Varanasi: 2017. p. 5. (reprint edition 2017) English translated, Susruta Samhita of Acharya Susruta Chikista Sthana [Chapter 1] Verse 7. [Google Scholar]
  • 13.Ramo Cusumano F., Baltimore M.D. United States Patent Office Serial No. 11,328. Patented; 1954. Antimicrobial impregnated Gauze pads and method of making same. [Google Scholar]
  • 14.Pradeep Shindhe, Killedar R.S., Laxmikant S.D., Santosh Y., Madiwalar M. Evaluation of wound healing activity of jatyadi ointment and jatyadi taila in the management of shuddha vrana - a randomised controlled trial. AAM. 2020;9(2):98–107. doi: 10.5455/AAM.85523. [cited April 29, 2022]; [DOI] [Google Scholar]
  • 15.Nguyen H., Morgan D.A., Forwood M.R. Sterilization of allograft bone: is 25 kGy the gold standard for gamma irradiation? Cell Tissue Bank. 2007;8(2):81–91. doi: 10.1007/s10561-006-9019-7. Epub 2006 Jul 5. PMID: 16821106. [DOI] [PubMed] [Google Scholar]
  • 16.Bates-Jensen B.M., McCreath H.E., Harputlu D., Patlan A. Reliability of the Bates-Jensen wound assessment tool for pressure injury assessment: the pressure ulcer detection study. Wound Repair Regen. 2019 Jul;27(4):386–395. doi: 10.1111/wrr.12714. Epub 2019 Mar 18. PMID: 30828890; PMCID: PMC6693585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Guo S., Dipietro L.A. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229. doi: 10.1177/0022034509359125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Frykberg Robert G., Banks Jaminelli. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015;4(9):560–582. doi: 10.1089/wound.2015.0635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Comparative study on the antibacterial activity of phytochemical flavanones against methicillin resistant Staphylococcus aureus. J Ethnopharmacol. 1996;50(1):27–34. doi: 10.1016/0378-8741(96)85514-0. PMID: 8778504 16. [DOI] [PubMed] [Google Scholar]
  • 20.Satheesh V Dev, Shailaja S., Sharma Vishwanath. A comparative clinical study on the effect of JatyadiTaila in varicose ulcer and diabetic ulcer. IAMJ. 2015;3(7):1952–1958. [Google Scholar]
  • 21.Dr Ganesh Krushna Garde Editor(s) Anmol Prakashan; 2007. Ashtang Hrudya of Vagbhat, Sutrasthan; Dravadravya vidnyaniya: Chapter 5, Verse 37-38. Pune-2; p. 20. (reprint 2007 Ed.) [Google Scholar]
  • 22.Kaviraj Ambikadatta Shastri Editor(s) Chaukhambha Sanskrit Sansthana; Varanasi: 2009. Sushruta Samhita of Sushruta, Sutrasthana; Drava dravya vidhi: Chapter 45, Verse 96; p. 228. (Reprint 2009 Ed.) [Google Scholar]
  • 23.Naureen I., Iqbal H., Aslam F., Jamal S., Sattar A., Zahid M. Antimicrobial and antioxidant activity of honey. Am Acad Scientif Res J Eng Technol Sci. 2022;87(1):204–217. [Google Scholar]
  • 24.Satheesh V Dev, Shailaja S.V., Sharma Vishwanath. A comparative clinical study on the effect of JatyadiTaila in varicose ulcer and diabetic ulcer. IAMJ. 2015;7:52–58. [Google Scholar]
  • 25.Minden-Birkenmaier B.A., Bowlin G.L. Honey-based templates in wound healing and tissue engineering. Bioengineered. 2018;5(2):46. doi: 10.3390/bioengineering5020046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gokhale A.B., Damre A.S., Kulkami K.R., Saraf M.N. Preliminary evaluation of anti-inflammatory and anti-arthritic activity of S. lappa, A. speciosa and A. aspera. Phytomedicine. 2002;9(5):433–437. doi: 10.1078/09447110260571689. PMID: 12222664. [DOI] [PubMed] [Google Scholar]
  • 27.Salehi B., Stojanović-Radić Z., Matejić J., Sharifi-Rad M., Kumar N.V., Martins N., et al. The therapeutic potential of curcumin: a review of clinical trials. Eur J Med Chem. 2019 Feb 1;163:527–545. doi: 10.1016/j.ejmech.2018.12.016. [DOI] [PubMed] [Google Scholar]
  • 28.Nooh H.Z., Nour-Eldien N.M. The dual anti-inflammatory and antioxidant activities of natural honey promote cell proliferation and neural regeneration in a rat model of colitis. Acta Histochem. 2016;118:588–595. doi: 10.1016/j.acthis.2016.06.006. [DOI] [PubMed] [Google Scholar]
  • 29.Moch D., Schewe Tankred, Kühn Hartmut, Schmidt D., Buntrock P. The linoleic acid metabolite 9DS-hydroxy-10, 12(E, Z) – octadecadienoic acid is a strong proinflammatory mediator in an experimental wound healing model of the rat. Biomed Biochim Acta. 1990;49:201–207. [PubMed] [Google Scholar]
  • 30.Waghmare S. D, Londhe Gaurav P, Dakhore Rajesh N, Patange Gauri P. Varicose Ulcer managed with Panchavalkala Kashaya and Jatyadi Taila- A Case Study 2019; 8(5):1321-1327.
  • 31.Singh A.K., Sharma A., Warren J., Madhavan S., Steele K., Rajesh Kumar N.V., et al. Source of support: nil conflict of interest: none Maheshwari RK.picroliv accelerates epithelialization and angiogenesis in rat wounds. Planta Med. 2007;73(3):251–256. doi: 10.1055/s-2007-967119. PMID: 17318779. [DOI] [PubMed] [Google Scholar]
  • 32.Raju Katari S., Alessandri Giulio, Ziche Marina, Pietro M., Ceruloplasmin Gullino. Copper Ions, and angiogenesis. J Natl Cancer Inst. 1982;69(5):1183–1188. [PubMed] [Google Scholar]
  • 33.Vijaya K.K., Nishteswar K. Wound healing activity of honey: a pilot study. Ayu. 2012;33(3):374–377. doi: 10.4103/0974-8520.108827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Ibrahim N.’, Wong S.K., Mohamed I.N., Chin K.Y., Ima-Nirwana S., Shuid A.N., et al. Wound healing properties of selected natural products. Int J Environ Res Publ Health. 2018;15(11):2360–PMC6266783. doi: 10.3390/ijerph15112360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Martinotti S., Ranzato E. Nova Publishers Inc.; Hauppauge, NY, USA: 2014. Cellular and molecular mechanisms of honey wound healing. [Google Scholar]
  • 36.Ranzato E., Martinotti S., Burlando B. Honey exposure stimulates wound repair of human dermal fibroblasts. Burns Trauma. 2013;1:32–38. doi: 10.4103/2321-3868.113333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kristo Nuutila, Elof Eriksso. Dec 2021. Advances in wound care; pp. 685–698. [DOI] [Google Scholar]
  • 38.Mishra Kumar Abhaya, Krishnapriya N.V Ramesh. Therapeutic uses of bees wax in Ayurveda and its physico chemical analyses: a review. Int J Res Ayurveda Pharm. 2017;8(1):25–26. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (104.3KB, docx)

Articles from Journal of Ayurveda and Integrative Medicine are provided here courtesy of Elsevier

RESOURCES